Insolvency

Mr David Hamilton: To ask the Secretary of State for Business, Innovation and Skills what steps his Department has taken to ensure that (a) shareholders and (b) other types of owners are not allowed to structure investment in companies in such a way as to become preferred creditors in the event of insolvency. [133849]

Jo Swinson: The order of priority in insolvency situations has been long established, and the list of preferred creditors is kept to an absolute minimum. Secured lending from whatever legitimate source is, however, vital to our commercial landscape and the elevated position of such lenders in the creditor hierarchy recognises its importance.

It will be for the appointed officeholder of an insolvent company to consider the nature of any transaction(s) that led to any charge(s) being obtained and the validity of security held.

Mr David Hamilton: To ask the Secretary of State for Business, Innovation and Skills what steps his Department has taken to ensure that genuine investment into a company cannot be registered as a loan in order to allow investors to become preferred creditors in the event of insolvency. [133850]

Jo Swinson: It is a fundamental feature of our securitisation and insolvency law that lenders are able to invest in companies by way of secured loans. Secured lending is vital to our commercial landscape, enabling businesses to obtain funding to trade where they may otherwise be unable to do so. Its importance is particularly recognised by the elevated position of such lenders in the creditor hierarchy.

Local Enterprise Partnerships

Mr Amess: To ask the Secretary of State for Business, Innovation and Skills what proportion of the population of England is covered by local enterprise partnerships; what plans he has to extend coverage; and if he will make a statement. [132631]

Michael Fallon: There are a total of 39 local enterprise partnerships which cover 100% of the population of England.

18 Dec 2012 : Column 734W

Local Enterprise Partnerships: Greater London

Mr Thomas: To ask the Secretary of State for Business, Innovation and Skills pursuant to the answer of 11 December 2012, Official Report, column 235W, on local economic partnerships: Greater London, if he will publish the terms of reference of the London enterprise panel capacity fund award; and if he will make a statement. [133996]

Michael Fallon: Guidance for the local enterprise partnership capacity fund is available on the Government's website:

https://www.gov.uk/government/publications/local-enterprise-partnership-capacity-fund-round-2

Money Lenders

Yvonne Fovargue: To ask the Secretary of State for Business, Innovation and Skills how many reports have been received by the illegal money lending teams in each (a) local authority area and (b) constituency; how many such reports resulted in further action being taken by the illegal money lending teams; and how many successful convictions of illegal money lenders have resulted from such reports in each of the last three years. [133918]

Jo Swinson: The Department does not hold this detailed level of information. Following the Government's reforms to the consumer landscape, since April 2012, the National Trading Standards Board now receives these reports, and reports to BIS in aggregate.

Until April 2012, BIS received quarterly aggregate reports from the tackling illegal money lending teams in England, Wales and Scotland based on activity in local authorities. Between April 2004 and April 2012, the projects had:

Identified over 2,500 illegal money lenders and arrested over 600 illegal money lenders and secured over 220 prosecutions, resulting in prison sentencing totalling over 117 years—some cases were connected to other, more serious criminal activity which took precedence over illegal money lending prosecutions.

Seized over £2.1 million in cash.

Identified over £28 million of assets that could be seized under the Proceeds of Crime Act.

Helped over 16,000 victims of loan sharks.

New Businesses

Mr Amess: To ask the Secretary of State for Business, Innovation and Skills what progress his Department is making on achieving the Government's aim of making the UK the best place to start a business; what recent discussions he has had with the Confederation of British Industry on business start-up; and if he will make a statement. [132456]

Michael Fallon: We want to make the UK the best place in the world to start and grow a business, and for the next decade to be the most entrepreneurial and dynamic in Britain's history. There were 450,000 new company registrations in 2011/12—the highest since records began in 1997-98 and up from 360,000 in 2009-10. The World Bank(1) ranks the UK third in the G7 and 19th overall in the world for ease of starting a business.

18 Dec 2012 : Column 735W

Lord Young was tasked by Government to assess the landscape for supporting new small businesses and his report and guide on small business start-ups and enterprise was published on 28 May 2012. A key message of his report was that this is a great time to start a business, with record numbers of people becoming their own boss, supported by a wide range of help and encouragement to entrepreneurs from all ages and backgrounds.

We continue to engage with the CBI, alongside other business representative bodies, to discuss a range of issues including barriers to start-ups. The Secretary of State meets with the CBI on a regular basis and discussions cover business financing, including our emerging proposals for a business bank.

(1 )Source:

Doing Business 2013 report

Occupational Health

Chris Ruane: To ask the Secretary of State for Business, Innovation and Skills what recent steps his Department has taken to promote best practice on workplace well-being. [134268]

Jo Swinson: This Department is committed to promoting a culture of workplace well-being, recognising that this is good for employees and also for employers.

A clear example of this is BIS's work to promote a culture of flexible working. As well as extending the right to request flexible working to all, we are working, with the Department for Work and Pensions (DWP) to drive culture change, particularly to encourage employers to think about the business benefits of flexible working when they recruit new employees. An employer group led by working families will be making practical recommendations about how businesses can benefit from flexible working and how they should consider building it into their recruitment practices.

This Department has also jointly sponsored the Sickness Absence Review with DWP, where Dame Carol Black and David Frost brought forward a series of recommendations intended to foster a more coherent approach, through encouraging employers and individuals to play a more proactive role in managing absence and return to work. The review was conducted in the context of the Growth Agenda and fed into the wider Employment Law Review. The Government will publish their response shortly.

BIS has also been a keen supporter of the excellent programme “Engage for Success”. This voluntary movement of leaders, managers and engagement practitioners is doing good work to promote the business benefits of effective employee engagement. “Engage for Success” recently launched a set of practical tools aimed at helping employers understand how to achieve employee engagement through focusing on four strategic enablers: strategic narrative; engaging managers; employee voice; and integrity. Further information can be found at:

www.engageforsuccess.org

BIS's partner organisations also have a role to play here, including the UK Commission for Employment and Skills (UKCES), which has responsibility for promoting Investors in People, a standard that puts employees and their interests at the heart of a business's success. In addition, ACAS also runs conferences to support workplace

18 Dec 2012 : Column 736W

health, as part of its work to promote best practice around creating a modern workplace. Its seminar entitled ‘Health and Engagement' took place in Birmingham on 13 December 2012 and a ‘Health and Well-being' conference is planned for March 2013 in Nottingham. ACAS have also published an advisory booklet on ‘Health, Work and Wellbeing', which is available on its website:

www.acas.org.uk

In taking this work forward, this Department works closely with DWP, which also has a keen policy interest in this subject.

Chris Ruane: To ask the Secretary of State for Business, Innovation and Skills what recent research his Department has conducted into the relationship between workplace well-being and productivity. [134269]

Jo Swinson: In October 2012 BIS published a study, ‘Promoting High Performance Working’, which assessed the prevalence of high performance working practices and the factors that influence their use in small and medium-sized enterprises. The presence of high performance work practices is associated with improved business performance and contributes to well-being; employees report higher job satisfaction, motivation, involvement and commitment. More information about high performance working can be found on the UK Commission for Employment and Skills (UKCES) website.

BIS has also published a series of Work-Life Balance Surveys which look at issues including working hours, the provision and take-up of flexible working arrangements, and employee attitudes to work-life balance.

These publications are available in the BIS area of the following website:

www.gov.uk

Recruitment

Mr Amess: To ask the Secretary of State for Business, Innovation and Skills how many civil servants his Department has recruited in each month since 2010; what the cost to the public purse was of such recruitment in each year since 2010; and if he will make a statement. [132310]

Jo Swinson: The number and cost of new entrants to the civil service recruited by the Department for Business, Innovation and Skills since May 2010 when the civil service recruitment freeze was implemented is given in the following tables. The tables also includes all leavers from the Department.

2010
 RecruitsLeavers

May

4

27

June

1

24

July

1

33

August

1

40

September

1

250

October

20

141

November

1

43

December

0

18

Total number

29

576

18 Dec 2012 : Column 737W

Total cost (£)

200,126

2011
 RecruitsLeavers

January

4

14

February

6

25

March

1

101

April

0

31

May

1

11

June

0

226

July

3

27

August

2

36

September

3

34

October

23

37

November

2

10

December

5

20

Total number

50

572

   

Total cost (£)

286,407

2012
 RecruitsLeavers

January

34

72

February

9

17

March

16

21

April

14

28

May

9

20

June

6

27

July

16

21

August

4

44

September

12

29

Total number

120

279

   

Total cost (£)

421,022

These figures include apprentices and graduate recruits from the civil service fast stream programme who are exempt from the recruitment freeze, as well as fixed term appointees recruited for their specialist expertise.

Mr Amess: To ask the Secretary of State for Business, Innovation and Skills what plans he has to recruit staff to posts in his Department in each of the next 12 months; and if he will make a statement. [132311]

Jo Swinson: Given the current recruitment freeze, external recruitment will be limited to bringing in those with skills that are not available or cannot be quickly developed internally as business critical vacancies arise. In addition, in the next financial year at more junior levels we are expecting to offer opportunities for up to 60 new entrants by using a combination of the civil service fast stream graduate recruitment programme, apprenticeships and graduate internships.

This represents around 2% of the total workforce of the core Department and UK Trade and Investment and is not expected to increase current headcount given turnover.

All other vacancies will be filled from within the civil service.

Regeneration: Essex

Mr Amess: To ask the Secretary of State for Business, Innovation and Skills what recent discussions

18 Dec 2012 : Column 738W

he has had with the Secretary of State for Communities and Local Government on regeneration in

(a)

Southend and

(b)

Essex. [132607]

Michael Fallon: The Secretary of State for Business, Innovation and Skills, the right hon. Member for Twickenham (Vince Cable) and the Secretary of State for Communities and Local Government, my right hon. Friend the Member for Brentwood and Ongar (Mr Pickles) meet frequently to discuss growth and regeneration issues, as do the Ministers of State responsible for local growth in BIS and CLG, but they have not met specifically to discuss Essex or Southend.

The South East LEP sets the economic priorities across Essex, Kent and East Sussex at a strategic level, with input from local authorities and business. The LEP has secured an Enterprise Zone at Harlow and is administering some £50 million of Growing Places Fund. Alongside that work, Southend is one of 20 cities invited by Government to propose a Wave 2 City Deal, on which work is progressing well.

The Thames Gateway South Essex Partnership brings together the Gateway boroughs, including Southend, to tackle the long term infrastructure and growth challenges of the area—overseen through the Thames Gateway Strategic Group by the Thames Gateway Minister, the Under-Secretary of State for Communities and Local Government, my hon. Friend the Member for Great Yarmouth (Brandon Lewis).

Officials in central and local government are working closely with each other and with the private sector to ensure coherence between these arrangements and to help achieve growth in the Essex economy.

Regional Growth Fund

Mr Umunna: To ask the Secretary of State for Business, Innovation and Skills pursuant to the answer of 27 November 2012, Official Report, column 298W, on regional growth fund, what the monetary value was of each individual award under round one of the regional growth fund which has not yet received a final agreed offer. [133771]

Michael Fallon: Seven individual awards from round one of the regional growth fund have not yet received a final agreed offer as the company has not been able to agree terms and conditions. The following table shows the monetary value of each of these awards. BIS officials aim to get these offers agreed by the end of the year.

NumberAmount (£ million)

1

4,010,000

2

12,900,000

3

4,000,000

4

2,000,000

5

1,300,000

6

3,600,000

7

17,850,000

Mr Umunna: To ask the Secretary of State for Business, Innovation and Skills pursuant to the answer of 9 November 2012, Official Report, column 779W, on regional growth fund, how many (a) bids and (b) individual awards under round one only of the regional

18 Dec 2012 : Column 739W

growth fund have not yet drawn down funds; and what the monetary value is of such bids and awards. [133773]

Michael Fallon: There were 67 successful bids under round 1. Twelve projects have since been withdrawn. and twenty-one projects with a total value of £88.5 million have not claimed payments to date.

Mr Umunna: To ask the Secretary of State for Business, Innovation and Skills pursuant to the answer of 27 November 2012, Official Report, column 298W, on regional growth fund, from which regions the awards under round one of the regional growth fund which have not yet agreed a final offer came. [134023]

Michael Fallon: Seven individual awards from round one of the regional growth fund have not yet received a final agreed offer as the company has not been able to agree terms and conditions. Of these, two are from the west midlands, one from the east midlands and two each from the north-east and north-west respectively.

Officials in the Department for Business, Innovation and Skills aim to get these offers agreed by the end of the year.

Secondment

Mr Umunna: To ask the Secretary of State for Business, Innovation and Skills (1) how many (a) secondments and (b) temporary transfers to his Department there have been of staff whose principal employer is (i) a non-departmental public body, (ii) an executive agency, (iii) a non-ministerial Government Department and (iv) another public body in (A) 2010-11, (B) 2011-12 and (C) 2012-13 to date; [134155]

(2) how many staff whose principal employer is (a) a non-departmental public body, (b) an Executive agency, (c) a non-ministerial Government Department and (d) another public body are currently working in his Department; and how many such staff there were in (i) 2011 and (ii) 2010. [134156]

Jo Swinson: The following table shows the number of (a) secondments and (b) temporary transfers to the Department for Business, Innovation and Skills (BIS)

18 Dec 2012 : Column 740W

whose principal employer is (i) a non-departmental public body (NDPB), (ii) an executive agency, (iii) a non-ministerial Government Department and (iv) another public body in (A) 2010-11, (B) 2011-12 and (C) 2012-13 to date.

 2010/112011/122012/13 to date

Secondment

   

NDPB

2

Public corporation

1

1

Public body

1

Executive agency

1

2

    

Loan in/temporary transfer

   

Non-ministerial Department

1

Another Government Department

90

Unknown

180

177

8

Total

183

180

101

The data for 2010/11 and 2011/12 do not show the breakdown by type of employer for loans or temporary transfers into the Department, as the Department has only recently started to capture these data. However, the majority of these are people coming into BIS from other Government Departments.

Health

Accident and Emergency Departments: Greater London

Mr Thomas: To ask the Secretary of State for Health how many people (a) attended accident and emergency (A and E) departments, (b) spent up to 120 minutes between arrival and departure in A and E, (c) spent between 121 and 240 minutes before departure in A and E and (d) spent over 240 minutes before departure in A and E in (i) North West London Hospitals NHS Trust and (ii) all London A and E departments in (A) 2010-11 and (B) 2011-12; and if he will make a statement. [133670]

Dr Poulter: The number of attendances at accident and emergency for the specified providers by the duration to departure for each attendance in 2010-11 and 2011-12 is shown in the following tables. Data for 2011-12 are provisional and are therefore subject to change.

Number of attendances(1) at accident and emergency for specified providers(2) by the duration to departure(3) for each attendance in 2010-11 and 2011-12 provisional(4), activity in English NHS hospitals and English NHS commissioned activity in the independent sector
  2010-11
  Duration to departure
   Minutes 
Provider codeProvider nameTotal attendances0-120121-240>240Unknown

RV8

North West London Hospitals NHS Trust

172,300

64,112

98,536

9,652

Q36

London SHA Treatment

3,274,513

1,284,888

1,809,444

179,155

1,026

18 Dec 2012 : Column 741W

18 Dec 2012 : Column 742W

  2011-12 (Provisional)
  Duration to departure
   Minutes 
Provider codeProvider nameTotal attendances0-120121-240>240Unknown

RV8

North West London Hospitals NHS Trust

206,885

105,392

91,286

10,207

Q36

London SHA Treatment

3,627,530

1,524,814

1,905,452

161,736

35,528

(1)A and E attendances Activity at A and E Departments is recorded as the number of attendances. It should be noted that an individual person may attend the same or different A and E departments within any given year and therefore this does not represent the number of patients. (2)A and E service providers A provider code is a unique code that identifies an organisation acting as a health care provider (e.g. NHS trust or primary care trust). Hospital providers can also include treatment centres (TC). Normally, if data are tabulated by health care provider, the figure for an NHS trust gives the activity of all the sites as one aggregated figure. However, in the case of those with embedded treatment centres, these data are quoted separately. In these cases, ‘-X’ is appended to the code for the rest of the trust, to remind users that the figures are for all sites of the trust excluding the treatment centres. The quality of TC returns are such that data may not be complete. Some NHS trusts have not registered their TC as a separate site, and it is therefore not possible to identify their activity separately. Data from some independent sector providers, where the onus for arrangement of dataflows is on the commissioner, may be missing. Care must be taken when using these data as the counts may be lower than true figures. (3)Duration to departure The total amount of time spent in the A and E department. This calculated as the difference in time from arrival at A and E to the time when the patient is discharged from A and E care. This includes being admitted to hospital, died in the department, discharged with no follow up or discharged—referred to another specialist department. (4)Provisional data The data are provisional and may be incomplete or contain errors for which no adjustments have yet been made. Counts produced from provisional data are likely to be lower than those generated for the same period in the final dataset. This shortfall will be most pronounced in the final month of the latest period i.e. November from the (month 9) April to November extract. It is also probable that clinical data are not complete, which may in particular affect the last two months of any given period. There may also be errors due to coding inconsistencies that have not yet been investigated and corrected. Data quality: Hospital Episode Statistics are compiled from data sent by more than 300 NHS trusts and primary care trusts in England and from some independent sector organisations for activity commissioned by the English NHS. The Health and Social Care Information Centre liaises closely with these organisations to encourage submission of complete and valid data and seeks to minimise inaccuracies. While this brings about improvement over time, some shortcomings remain. Source: Hospital Episode Statistics (HES), Health and Social Care Information Centre.

Antibiotics: Research

Mr Barron: To ask the Secretary of State for Health when the UK Five Year Anti-Microbial Resistance Strategy and Action Plan will be published. [134262]

Dr Poulter: The UK Five Year Antimicrobial Resistance Strategy and Action Plan 2013-2018 is expected to be published in February 2013.

Blood

Andy Burnham: To ask the Secretary of State for Health how many units of blood were collected by NHS Blood and Transplant England in each of the last 12 months for which data is available. [134390]

Dr Poulter: NHS Blood and Transplant (NHSBT) is responsible for the provision of a reliable, efficient supply of blood to hospitals in England and North Wales.

The number of units of blood collected is set out in the following table:

Monthly whole blood collections by NHSBT in England and North Wales
 EnglandNorth WalesMonthly totals for whole blood collections in England and North Wales

2011

   

December

153,094

1,788

154,882

    

2012

   

January

166,662

1,738

168,400

February

152,498

1,366

153,864

March

160,467

1,860

162,327

April

158,486

1,658

160,144

May

169,626

1,833

171,459

June

153,001

1,588

154,589

July

164,582

1,707

166,289

August

161,736

1,731

163,467

September

141,887

1,695

143,582

October

162,792

1,514

164,306

November

162,183

1,630

163,813

Overall total number of whole blood collections in last 12 months

1,927,122

Source: NHS Blood and Transplant

18 Dec 2012 : Column 743W

Castlebeck

Andy Burnham: To ask the Secretary of State for Health whether he has received a full copy of the review for Castlebeck produced by PricewaterhouseCoopers for Castlebeck Limited. [134387]

Norman Lamb: The Secretary of State for Health, the right hon. Member for South West Surrey (Mr Hunt), has not received a full copy of the internal review for Castlebeck Ltd produced by PricewaterhouseCoopers.

Death: Winter

Andy Burnham: To ask the Secretary of State for Health how many excess winter deaths there were in England in each year since 1997. [134389]

Dr Poulter: The Office for National Statistics publishes national statistics detailing the number of excess winter deaths in England annually. Excess winter deaths are calculated as the difference between the number of deaths during the four winter months (December to March) and the average number of deaths during the preceding autumn (August to November) and the following summer (April to July). Figures for the latest winter season (2011-12) are provisional and rounded to the nearest 100; figures for all other winters are final and rounded to the nearest 10.

Number of excess winter deaths in England, 1997-98 to 2011-12
Winter seasonExcess winter deaths

1997-98

21,740

1998-99

44,010

1999-2000

45,650

2000-01

23,290

2001-02

25,790

2002-03

22,620

2003-04

21,930

2004-05

29,740

2005-06

23,740

2006-07

22,380

2007-08

23,290

2008-09

34,000

2009-10

24,170

2010-11

24,120

2011-12

22,800

Source: Office for National Statistics Excess Winter Mortality in England and Wales, 2011-12 (Provisional) and 2010-11 (Final), published 29 November 2012: www.ons.gov.uk/ons/rel/subnational-health2/excess-winter-mortality-in-england-and-wales/2011-12--provisional--and-2010-11--final-/index.html

Epilepsy

David Wright: To ask the Secretary of State for Health (1) what representations he has received on the effectiveness of the Government's strategy on (a) epilepsy diagnosis and management and (b) sudden death and epilepsy; and if he will make a statement; [134050]

(2) whether the Government intend to review their strategy on sudden death and epilepsy. [134051]

18 Dec 2012 : Column 744W

Norman Lamb: Ministers and officials have meetings and receive representations from a wide range of organisations and individuals as part of the process of policy development and delivery. These include representations on all aspects of epilepsy care as well as sudden unexpected death in epilepsy. As was the case with previous Administrations, it is not the Government's practice to provide details of all such meetings and representations.

The previous Administration published the national service framework (NSF) for long-term conditions in 2005 as a 10-year strategy to improve access, experience and outcomes for people with a long-term neurological condition. By implementing the NSF's quality requirements, local service commissioners would support improvements to areas such as diagnosis/treatment and information provision, which would reduce the risk of seizures and epilepsy related deaths. We have made no overall assessment of the effectiveness of implementation of the NSF, though the long-term neurological conditions research initiative has provided some information on its impact.

The mandate to the NHS Commissioning Board sets out the objectives for the national health service and highlights the areas of health and care where the Government expect to see improvements. The objectives in the mandate focus on those areas identified as being of greatest importance to people and include managing ongoing physical and mental health conditions. In this respect, the mandate seeks improvements in the way care is provided to people by centring care on the person rather than on the specific condition.

EU Law

Priti Patel: To ask the Secretary of State for Health (1) which EU directives his Department transposed in (a) 2011 and (b) 2012 to date; which EU directives his Department expects to transpose in (i) 2013 and (ii) the next two years; and what estimate he has made of the cost of each such directive to the (A) public purse and (B) private sector; [133703]

(2) which regulations his Department introduced as a result of EU legislation in (a) 2011 and (b) 2012 to date; which regulations his Department expects to implement as a result of EU legislation in (i) 2013 and (ii) the next two years; and what estimate he has made of the cost of each such regulation to the (A) public purse and (B) private sector. [133704]

Dr Poulter: The Department of Health is responsible for the transposition of the following European Union (EU) directives into United Kingdom law and introducing the following regulations as a result of EU legislation:

1. EU directives transposed or to be transposed:

Directive 2010/53/EU (organ transplantation)

Directive 2010/53/EU on standards of quality and safety of human organs intended for transplantation was transposed by the deadline, 27 August 2012. The estimated set-up cost for the public sector (NHS both centrally and at transplant centres) is £2.758 million, with an ongoing cost over a 10-year period of around £1.605 million per year. Over the same period, the set-up cost for the private sector was estimated at £300,000 with an annual ongoing cost of £345,000.

18 Dec 2012 : Column 745W

Directive 2010/84/EU (Pharmacovigilance)

The Department transposed directive 2010/84/EU amending, as regards pharmacovigilance, directive 2001/83/EC on the Community code relating to medicinal products for human use in July 2012. The final impact assessment identified annual cost to UK business at £4.6 million (annual costs £7.6 million, annual benefits £3.0 million).

Directive 2011/24/EU (cross border healthcare)

We plan to implement directive 2011/24/EU on cross border health care allowing EU citizens to seek planned health care treatment in other EU member states on 25 October 2013. The estimated costs and benefits of implementing the directive will be included in an impact assessment as part of the Department's consultation process now planned by spring 2013.

Directive 2011/62/EU (falsified medicines)

We will transpose directive 2011/62/EU in 2013. An initial assessment of the costs of the directive has been made in a current public consultation. This assessment identifies annual cost to UK business at £13.1 million (annual costs £13.11 million, annual benefits £0.013 million).

Directive 2011/100/EU (in vitro diagnostic medical devices)

Directive 2011/100/EU, placing variant Creutzfeld-Jacob disease (vCJD) assays into a technical annex of directive 98/79/EC that subjects in vitro diagnostic medical devices (IVDs) to the greatest level of pre-market scrutiny, was transposed in May 2012. The current costs on the public and private sector, as set out in the final impact assessment, are estimated to be nil insofar as there are not currently any vCJD IVDs on the market. The potential future costs per assay are estimated to have a one-off cost of between £12,000 and £18,000 and annual costs of between £9,000 and £10,000.

Directive 2012/15/EU

The Department need to transpose Commission implementing directive 2012/15/EU laying down information procedures for the exchange, between member states, of human organs, intended for transplantation but hope to do so by amending a definition in the Quality and Safety of Organs Intended for Transplantation Regulations 2012 (2012 No. 1501). Moreover, the present policy thinking is that the amendment might be included with other tissue regulations so there would be no significant extra cost.

Directive 2012/26/EU (Pharmacovigilance)

The Department will transpose directive 2012/26/EU amending, as regards pharmacovigilance, directive 2001/83/EC on the Community code relating to medicinal products for human use in October 2013. This directive makes minor procedural amendments and we do not expect additional costs.

2. Regulations introduced as a result of EU legislation including technical amendments:

Commission regulation (EU) No. 712/2012 of 3 August 2012 amending regulation (EC) No. 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products:

This regulation has led to some technical amendment of the Medicines (Products for Human Use) (Fees) Regulations 2012 (SI 2012/504). The amending statutory instrument (SI) is the Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2012 (SI 2012/712) which came into force on 2 November 2012.

18 Dec 2012 : Column 746W

This regulation did not lead to additional annual costs.

Further technical amendments based on Commission regulation (EC) 712/2012 will be included in the Medicines (Products for Human Use) (Fees) Regulations 2013.

The Human Medicines Regulations 2012

The Human Medicines Regulations 2012 (SI No. 2012/1916) implement directive 2010/84/EU amending as regards pharmacovigilance directive 2001/83/EC and regulation (EU) 1235/2010 amending as regards pharmacovigilance regulation (EC) No. 726/2004.

The Medical Devices (Amendment) Regulations 2012

The Medical Devices (Amendment) Regulations 2012 (SI 2012/1426) implement directive 2011/100/EU amending directive 98/79/EC on in vitro diagnostic medical devices.

Regulation 722/2012

Regulations to be made to implement Regulation 722/2012 concerning particular requirements as regards the requirements laid down in Council directives 90/385/EEC and 93/42/EEC with respect to active implantable medical devices and medical devices manufactured utilising tissues of animal origin; maximum cost on UK private sector of £24,000 per annum.

Commission Implementing Regulation (EU) No. 520/2012

Regulations to be made to implement Commission implementing regulation (EU) No. 520/2012 on the performance of pharmacovigilance activities provided for in regulation (EC) No. 726/2004 and directive 2001/83/EC. These regulations will jointly implement this regulation and the falsified medicines directive.

3. Directives not yet transposed

Directive 2009/39 (PARNUTS)

The PARNUTS directive for particular nutritional uses (directive 2009/39) is subject to an implementation timetable. It is close to political agreement which would lead to UK implementing regulations in 2015 or 2016.

The following directives and regulations are currently under negotiation and are not expected to be fully transposed or to enter into force before 2015-16. These include:

Directive 2001/83/EC, regulation (EC) No. 178/2002 and regulation (EC) No. 1223/2009 and proposal for a regulation of the European Parliament and of the Council on in vitro diagnostic medical devices.

Proposal for a decision of the European Parliament and of the Council on serious cross border threats to health.

Proposal for a regulation of the European Parliament and of the Council on establishing a Health for Growth Programme, the third multi-annual programme of EU action in the field of health for the period 2014-2020 (First Reading).

Proposal for a directive amending Council directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion within the scope of national health insurance systems.

Regulation on clinical trials on medical products for human use.

In order to increase transparency, in the forthcoming Statement of New Regulation (SNR5) the Government will, for the first time, be publishing those new EU measures which are being implemented in UK law and have a direct effect on business.

18 Dec 2012 : Column 747W

Health Professions: Training

Andy Burnham: To ask the Secretary of State for Health how many students entered training to become a (a) nurse, (b) midwife and (c) GP in England in each of the last five years. [134388]

Dr Poulter: The Department does not collect figures on nurses and midwives entering training. However, the number of training places commissioned for nursing and midwifery is collected.

The following table shows the number of full-time equivalent commissions for nursing and midwifery in the last five years.

Nursing and midwifery training commissions 2007-08 to 2011-12
 Commissions
 NursingMidwifery

2007-08

19,352

2,071

2008-09

20,663

2,272

2009-10

20,829

2,482

2010-11

20,092

2,488

2011-12

17,741

2,484

Note: The midwifery figures include both degree and 18 month diploma courses. Source: Multi-professional education and training monitoring returns

The actual number of training commissions for nurses and midwives in 2012-13 will not be available until May 2013.

The number of general practitioner trainees appointed for 2008 is not held by the Department. The numbers appointed in England since 2009 are shown in the following table.

18 Dec 2012 : Column 748W

General practitioner trainee appointments 2009-12
 Number

2009

2,691

2010

2,800

2011

2,658

2012

2,669

Source: www.openrecruitment.org.uk

Heart Diseases: Children

Rachel Reeves: To ask the Secretary of State for Health how many times paediatric cardiac transplant services have been moved between hospitals in the last 20 years; and how long the process took to complete for each such transfer. [134461]

Dr Poulter: There have been no occasions where paediatric cardiac transplant services have been moved between hospitals.

Hernias: Greater London

Mr Thomas: To ask the Secretary of State for Health how many finished admissions episodes there were and what the (a) mean and (b) median time waited was in days for hernia repair procedures in (i) North West London Hospitals NHS Trust and (ii) all London acute hospitals in (A) 2010-11 and (B) 2011-12; and if he will make a statement. [133669]

Dr Poulter: The number of finished admission episodes (FAEs) and mean and median time waited (days) for hernia repair procedures during 2010-11 and 2011-12 for North West London Hospitals NHS Trust and London strategic health authority is shown in the following table.

Number of finished admission episodes (FAEs)(1) and mean and median time waited(2) (days) for North West London Hospitals NHS Trust and for London strategic health authority (SHA) of treatment for hernia repair procedures(3) for 2010-11 and 2011-12, activity in English NHS hospitals and English NHS commissioned activity in the independent sector
  2010-112011-12
Procedure Total FAEsMean time waitedMedian time waitedTotal FAEsMean time waitedMedian time waited

Hernia repair

North West London Hospitals NHS Trust

790

71.7

70

830

127.0

150

 

London SHA Treatment

15,955

70.5

62

16,739

80.5

67

(1)Finished admission episodes A finished admission episode (FAE) is the first period of in-patient care under one consultant within one health care provider. FAEs are counted against the year in which the admission episode finishes. Admissions do not represent the number of in-patients, as a person may have more than one admission within the year. (2)Time waited (days) Time waited (days) statistics from Hospital Episode Statistics (HES) are not the same as published Referral to Treatment (RTT) time waited statistics. HES provides counts and time waited for all patients between decision to admit and admission to hospital within a given period. Published RTT waiting statistics measure the time waited between referral and start of treatment. (3)Duration to departure The total amount of time spent in the accident and emergency A and E department. This is calculated as the difference in time from arrival at A and E to the time when the patient is discharged from A and E care. This includes being admitted to hospital, died in the department, discharged with no follow up or discharged—referred to another specialist department. Source: Hospital Episode Statistics (HES), Health and Social Care Information Centre.

HIV Infection

Mike Freer: To ask the Secretary of State for Health when his Department's updated HIV strategy will be published. [133803]

Dr Poulter: HIV will be covered in the sexual health policy document which will set out the framework for improving all aspects of sexual health including HIV in England. We plan to publish the document as soon as possible.

Hospitals: Admissions

Paul Blomfield: To ask the Secretary of State for Health how many (a) discharges and (b) emergency readmissions within 28 days of discharge for those aged over 75 there were, in line with Hospital Episode Statistics measurement guidelines, by primary care trust, in 2011-12. [133629]

Anna Soubry: Information on the number of emergency readmissions within 28 days of discharge for 2011-12 is

18 Dec 2012 : Column 749W

not yet available. Information on the standardised rate of emergency readmissions by primary care trust (the number of emergency readmissions divided by the number of discharges, standardised for changes in case mix) is available for 2010-11 and earlier years from the website of the Health and Social Care Information Centre at:

https://indicators.ic.nhs.uk/webview/

Injuries: Fireworks

Andrew Rosindell: To ask the Secretary of State for Health (1) if he will estimate the cost of firework-related injuries to the NHS in the last 12 months; [133860]

(2) how many people were admitted to hospital for firework-related injuries in England in the last 12 months. [133861]

Dr Poulter: The Department does not collect the cost to the national health service of treating firework-related injuries. There were 164 finished admission episodes of people admitted to hospital with an external cause code of W39—Discharge of Firework—in 2011-12(1). This figure is not a count of all admissions for firework-related injuries, only those with this specific external cause recorded.

(1) Note: A finished admission episode (FAE) is the first period of inpatient care under one consultant within one healthcare provider. FAEs are counted against the year in which the admission episode finishes. Admissions do not represent the number of inpatients, as a person may have more than one admission within the year.

Source:

Hospital Episode Statistics, Health and Social Care Information Centre

Medicine: Research

Mr David Davis: To ask the Secretary of State for Health (1) what steps he plans to take to increase the availability of clinical data for research. [134170]

(2) what discussions he has had with the European Medicines Agency and the Medicines and Healthcare Products Regulatory Agency on whether clinical data should be published for the purposes of research. [134171]

Dr Poulter: The Government launched the Clinical Practice Research Datalink (CPRD) in March 2012. As agreed in the “Strategy for UK Life Sciences”, the CPRD is the result of a £60 million investment by the National Institute for Health Research and the Medicines and Healthcare products Regulatory Agency (MHRA) and will provide access to data that support clinical trials and population observational studies on an unprecedented scale.

The CPRD operates across England, connecting patient information from general practitioners and hospitals to other records, such as disease registries, and holds the resultant information in anonymised form to protect patients’ privacy. The combined datasets can be used to answer medical research questions, and the results shared via peer reviewed publications. Future projects include the addition of air pollution data, social care records and potential for working with UK Biobank. The CPRD also aims to link with similar systems that cover populations in Scotland and Wales. Governance approval is sought for all new data linkages.

18 Dec 2012 : Column 750W

Since the service was launched in March 2012, 16 global pharmaceutical companies have been granted CPRD data licences, over 100 research studies have been submitted and 623 researchers have registered on the CPRD website. We will build on this early platform to provide an invaluable resource for the research community.

Clinical data and linked data, in a research-usable, anonymised format, are made available via the CPRD to a wide range of researchers for use in approved research projects. These research projects meet the needs of medicine/device regulators as well the needs of commercial companies required under regulations to undertake specific research studies. Discussions between CPRD and researchers, regulators and commercial companies are conducted on a regular basis to ensure the role that United Kingdom data can play in medicine/device safety and improvement in public health is maximised. The anonymised data are published against a specific independently approved protocol written by researchers who are under legal contract to CPRD for access to the required dataset for each research study protocol.

The CPRD is also developing specific data/research tools to help the understanding of the use of medicines in pregnancy and in children, as well as in the immediate period after launch of a new medicine. These tools are in response to the requirements of regulators such as the European Medicines Agency and the MHRA.

To complement the work of the CPRD, the Health and Social Care Information Centre (HSCIC) launched its new data linkage service on 17 September 2012, in line with commitments set out in the “Strategy for UK Life Sciences”. The data linkage service adds significant value to individual sets of data by combining and matching them at an anonymised individual record level in a secure environment. From April 2013 the service will begin to offer anonymised extracts of linked data on a routine (i.e. monthly) basis. The volume of extracts available will grow as the datasets within the HSCIC increase. HSCIC is working with the CPRD and the Association of the British Pharmaceutical Industry to identify priority areas for linkage.

Sir David Nicholson will lead on delivering the national health service vision for genomics, starting with a process to ensure that from April 2014 contracts are in place for whole genome sequences for NHS patients. Access arrangements will be considered as part of this process. To ensure public confidence in matters of confidentiality and access, this work will be monitored by the chief medical officer for England. Access would only be to anonymised and aggregated data to carry out research likely to benefit the health of UK citizens. The NHS will act as custodians of these data, ensuring that doctors have the information they need and researchers can carry out health research while privacy of the patients is ensured.

Meningitis: Vaccination

Dr Offord: To ask the Secretary of State for Health what the timeframe is for the introduction of the MenB vaccination. [133722]

Dr Poulter: There are currently no authorised vaccines available to protect against meningococcal B. However, a meningococcal B vaccine (Bexero) has been recommended recently by the European Medicines Agency for market

18 Dec 2012 : Column 751W

authorisation. In anticipation of the availability of a meningococcal B vaccine, the Joint Committee on Vaccination and Immunisation (JCVI—the independent expert committee that provides advice to Government on immunisation) is evaluating possible meningococcal B vaccination strategies. As part of this assessment, JCVI is considering evidence on the epidemiology and carriage of different meningococcal serogroup B strains, the costs of treating meningococcal serogroup B disease and the costs of treating the long-term conditions that result from this disease, as well as the quality of life of affected individuals.

JCVI's evaluation is expected to be completed during 2013.

The Department will consider the advice of JCVI once received and depending on the advice, the possible introduction of a meningococcal B vaccination programme in conjunction with the NHS Commissioning Board and Public Health England.

NHS: Per Capita Costs

Andy Burnham: To ask the Secretary of State for Health what the net expenditure per head by the NHS was in England in each of the last five years. [134391]

Dr Poulter: The following table shows total net NHS expenditure and NHS expenditure per head for England 2006-07 to 2010-11. Data for 2011-12 are not yet available.

Net NHS Expenditure2006-072007-082008-092009-102010-11

Total Expenditure (£ million)

76,926

83,335

90,035

97,272

99,249

Expenditure per head (£)

1,515

1,631

1,749

1,877

1,900

Source: HM Treasury Public Expenditure Statistical Analyses 2012 (Tables 9.11 and 9.15).

North of England Cancer Network

Grahame M. Morris: To ask the Secretary of State for Health (1) what funding his Department has provided to the North of England Cancer Network in each of the last four financial years; [133642]

(2) how many members of staff have been employed by the North of England Cancer Network in each of the last four financial years; [133749]

(3) if he will meet hon. Members to discuss the steps his Department intends to take to safeguard the services provided by the (a) North of England Cancer Network and (b) North of England Cardiovascular Network. [133750]

Dr Poulter: Information concerning the funding received by the North East Cancer Network in last four years and its staffing levels during that time is not held centrally. Funding to support cancer networks is mainly provided through what is called the Strategic Health Authority (SHA) bundle. However, it is for each SHA to determine how the total amount they receive in the SHA bundle is allocated to specific services, such as cancer networks, taking into account the needs of local populations. Staffing levels for cancer networks are a matter for local national health service organisations.

The NHS Commissioning Board (NHS CB) Authority has set out its plans to establish a small number of national networks to improve health services for specific

18 Dec 2012 : Column 752W

patient groups or conditions, such as cancer and cardiovascular disease. Called strategic clinical networks, from 1 April 2013, these organisations will build on the success of network activity, which, over the last 10 years, has led to significant improvements in the delivery of patient care. Funding allocated for clinical networks in 2013-14 is £42 million.

These networks will exist for up to five years and will be managed by 12 locally based support teams. All primary care trusts have developed comprehensive legacy documents and network activities are included in these. In particular, it will be the role of the 12 associate directors who will lead the network support teams to ensure that the transition is well managed at a local level. The NHS CB expects that the associate directors posts and network manager posts will be recruited to shortly, and it is likely that many of the successful applicants will be individuals already engaged in clinical network activity. We have been advised that that there will be some continuity between North East Cancer network and the new network support team.

Nutrition

Ms Abbott: To ask the Secretary of State for Health whether his Department will continue with the Supermeals campaign in 2013; and how much will be spent on any forthcoming campaigns to promote healthy eating, including the budget for promotion, advertising, social media and securing public figures to be part of it. [134456]

Dr Poulter: Last year's Supermeals campaign was part of the ongoing Change4Life programme which encourages people to

“eat well, move more, live longer”.

Building on the success of Supermeals the Department will be launching a new healthy eating campaign in January 2013.

The planned budget (excluding VAT) for January's campaign is as follows:

Media (including Television, Radio and Press, Paid Search and Online Display Advertising): £1,975,000

Social Media: £10,000

No public figures are being paid to promote the campaign.

The planned budget is provisional as the campaign is being finalised.

Obstetrics: Greater London

Mr Thomas: To ask the Secretary of State for Health how many vacancies there were for (a) doctors and (b) nurses specialising in obstetrics in each NHS trust providing maternity services in the London Strategic Health Authority area (i) in total and (ii) by NHS trust in March (A) 2010 and (B) 2011; and if he will make a statement. [133668]

Dr Poulter: The information is not available in the format requested. The following table shows vacancy rates and numbers for consultants and midwives in the obstetrics and gynaecology speciality in the London Strategic Health Authority (SHA) area as at 31 March 2010.

18 Dec 2012 : Column 753W

The NHS and GP vacancy collections and publications have been suspended since 2011 pending the outcome of

18 Dec 2012 : Column 754W

the Department of Health-led Fundamental Review of Data Returns.

Total and three month vacancy rates and numbers for all consultants in the obstetrics and gynaecology specialty in London Strategic Health Authority
   Obstetrics and gynaecology
   Vacancy rate (%)Vacancy (No.)Three month vacancy rate (%)Three month vacancy (No.)Staff in post (full-time equivalents)Staff in post (headcount)
         

England

  

2.2

36

0.5

9

1,599

1,670

         

London

 

Q36

2.2

8

0.5

2

345

373

 

Barking and Dagenham Primary Care Trust (PCT)

5C2

0

0

0

0

 

Barking, Havering and Redbridge University Hospitals NHS Trust

RF4

0.0

0

0.0

0

18

18

 

Barnet and Chase Farm Hospitals NHS Trust

RVL

8.5

1

0.0

0

11

12

 

Barnet PCT

5A9

*

0

*

0

0

0

 

Barts and The London NHS Trust

RNJ

0.0

0

0.0

0

18

18

 

Bexley Care Trust

TAK

0

0

0

0

 

Brent Teaching PCT

5K5

0

0

0

0

 

Bromley PCT

5A7

0

0

0

0

 

Camden PCT

5K7

*

0

*

0

4

5

 

Chelsea and Westminster Hospital NHS Foundation Trust

RQM

0.0

0

0.0

0

20

23

 

City and Hackney Teaching PCT

5C3

0

0

0

0

 

Croydon PCT

5K9

0

0

0

0

 

Ealing Hospital NHS Trust

RC3

*

0

*

0

6

6

 

Ealing PCT

5HX

0

0

0

0

 

Enfield PCT

5C1

*

1

*

1

0

0

 

Epsom and St Helier University Hospitals NHS Trust

RVR

0.0

0

0.0

0

10

11

 

Great Ormond Street Hospital For Children NHS Trust

RP4

0

0

0

0

 

Greenwich Teaching PCT

5A8

0

0

0

0

 

Guy's and St Thomas' NHS Foundation Trust

RJ1

0.0

0

0.0

0

22

22

 

Hammersmith and Fulham PCT

5H1

0

0

0

0

 

Haringey Teaching PCT

5C9

0

0

0

0

 

Harrow PCT

5K6

0

0

0

0

 

Havering PCT

5A4

0

0

0

0

 

The Hillingdon Hospital NHS Trust

RAS

*

1

*

1

7

7

 

Hillingdon PCT

5AT

0

0

0

0

 

Homerton University Hospital NHS Foundation Trust

RQX

9.5

1

*

0

10

10

 

Hounslow PCT

5HY

0

0

0

0

 

Imperial College Healthcare NHS Trust

RYJ

0.0

0

0.0

0

34

41

 

Islington PCT

5K8

0

0

0

0

 

Kensington and Chelsea PCT

5LA

0

0

0

0

 

King's College Hospital NHS Foundation Trust

RJZ

0.0

0

0.0

0

21

23

18 Dec 2012 : Column 755W

18 Dec 2012 : Column 756W

 

Kingston Hospital NHS Trust

RAX

0.0

0

0.0

0

11

11

 

Kingston PCT

5A5

0

0

0

0

 

Lambeth PCT

5LD

0

0

0

0

 

The Lewisham Hospital NHS Trust

RJ2

*

0

*

0

7

7

 

Lewisham PCT

5LF

0

0

0

0

 

London

Q36

0

0

0

0

 

Mayday Healthcare NHS Trust

RJ6

*

0

*

0

7

7

 

Moorfields Eye Hospital NHS Foundation Trust

RP6

0

0

0

0

 

Newham PCT

5C5

*

0

*

0

1

1

 

Newham University Hospital NHS Trust

RNH

0.0

0

0.0

0

12

12

 

North Middlesex University Hospital NHS Trust

RAP

*

2

*

0

7

7

 

North West London Hospitals NHS Trust

RV8

0.0

0

0.0

0

15

16

 

Redbridge PCT

5NA

0

0

0

0

 

Richmond and Twickenham PCT

5M6

0

0

0

0

 

Royal Brompton and Harefield NHS Foundation Trust

RT3

0

0

0

0

 

Royal Free Hampstead NHS Trust

RAL

0.0

0

0.0

0

14

16

 

The Royal Marsden NHS Foundation Trust

RPY

*

0

*

0

4

4

 

Royal National Orthopaedic Hospital NHS Trust

RAN

0

0

0

0

 

South London Healthcare NHS Trust

RYQ

8.9

2

0.0

0

20

19

 

Southwark PCT

5LE

0

0

0

0

 

St George's Healthcare NHS Trust

RJ7

0.0

0

0.0

0

14

15

 

Sutton and Merton PCT

5M7

0

0

0

0

 

Tower Hamlets PCT

5C4

*

0

*

0

1

1

 

University College London Hospitals NHS Foundation Trust

RRV

0.0

0

0.0

0

26

29

 

Wandsworth PCT

5LG

0

0

0

0

 

West London Mental Health NHS Trust

RKL

0

0

0

0

 

West Middlesex University Hospital NHS Trust

RFW

*

0

*

0

7

8

 

Westminster PCT

5LC

0

0

0

0

 

Whipps Cross University Hospital NHS Trust

RGC

*

0

*

0

8

8

18 Dec 2012 : Column 757W

18 Dec 2012 : Column 758W

 

The Whittington Hospital NHS Trust

RKE

0.0

0

0.0

0

14

16

‘*’ = Figures where staff in post and number of vacancies are less than 10. ‘—’ = Figures where staff in post and vacancies are both nil. Notes: 1. SHA figures are based on trusts and do not necessarily reflect the geographical provision of healthcare. 2. A vacancy is defined as one which employers are actively trying to fill as at 31 March. 3. Total vacancy rates are total vacancies expressed as a percentage of total vacancies plus staff in post from the previous September medical and dental workforce census (full-time equivalent). 4. Three month vacancies are vacancies as at 31 March 2010 which trusts are actively trying to fill which had lasted for three months or more (full-time equivalents). 5. Three month vacancy rates are three month vacancies expressed as a percentage of three month vacancies plus staff in post from the previous September medical and dental workforce census (full-time equivalent). 6. Vacancy and staff in post numbers are rounded to the nearest whole number. 7. Percentages are calculated on unrounded figures and are then rounded to one decimal place. 8. Data Quality—The NHS Information Centre for health and social care seeks to minimise inaccuracies and the effect of missing and invalid data but responsibility for data accuracy lies. Source: The Health and Social Care Information Centre Vacancies Survey March 2010

Official Cars

Fabian Hamilton: To ask the Secretary of State for Health which Ministers in his Department have been allocated Government cars; and what the last dates were on which such cars were used by each Minister for (a) individual and (b) pool car use. [133798]

Dr Poulter: The Department has one allocated Government car which is used by the entire ministerial team. As at close of business on the 12 December 2012 the car was last used by each Minister on the following dates:

 Date

Secretary of State for Health (Mr Jeremy Hunt)

12 December 2012

Minister of State for Health (Mr Norman Lamb)

12 December 2012

Parliamentary Under-Secretary of State for Health (Dr Daniel Poulter)

30 November 2012

Parliamentary Under-Secretary of State for Health (The Earl Howe)

4 December 2012

Parliamentary Under-Secretary of State for Health (Anna Soubry)

10 December 2012

As at close of business on the 12 December 2012 Ministers last used the Government Car Service pool car service on the following dates:

 Date

Minister of State for Health (Mr Norman Lamb)

12 December 2012

Parliamentary Under-Secretary Secretary of State for Health (Dr Daniel Poulter)

12 December 2012

Parliamentary Under-Secretary of State for Health (The Earl Howe)

6 December 2012

Parliamentary Under-Secretary of State for Health (Anna Soubry)

6 December 2012